• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Advertisement
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Society

Anti-TB Drug Pretomanid

July 24, 2020
in Society
Reading Time: 2 mins read
0
Anti-TB Drug Pretomanid
21
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook
image_pdfMake PDF

Drugs Controller General of India (DCGI) has approved anti-tuberculosis drug pretomanid for conditional access under the National Tuberculosis Elimination Programme. Pretomanid has been developed by non-profit organisation TB Alliance. 

Anti-TB Drug Pretomanid

It is part of a 3-drug, 6-month, all-oral regimen for treatment of pulmonary extensively drug-resistant TB and non-responsive multi drug-resistant TB. Pretomanid is an investigational tuberculosis (TB) drug developed by TB Alliance for use in combination with bedaquiline and linezolid for treating a limited and specific population of adult patients with extensively drug-resistant, treatment-intolerant or non-responsive multidrug-resistant pulmonary TB.

Pretomanid is a new chemical entity and a member of a class of compounds known as nitroimidazooxazines. Novel compounds are important in pursuing new TB treatments because resistance to drugs and drug classes currently used to treat TB is widespread. It was developed as an oral tablet formulation for the treatment of tuberculosis in combination with other anti-tuberculosis agents. One such combination is BPaL ( bedaquiline + pretomanid + linezolid).

Current therapy for drug-resistant TB often requires people to take drugs for 6 months to 2 years or longer—or risk developing more difficult to treat drug-resistant TB. The WHO reports historical treatment success for XDR-TB at about 34%. BPaL has been tested in drug-resistant TB patients co-infected with HIV, including those receiving antiretrovirals (ARVs).

Pretomanid Tablets are not indicated for patients with:

  • Drug-sensitive (DS) tuberculosis
  • Latent infection due to Mycobacterium tuberculosis
  • Extra-pulmonary infection due to Mycobacterium tuberculosis
  • MDR-TB that is not treatment-intolerant or non-responsive to standard therapy
image_pdfMake PDF
Source: The Hindu, TB Alliance website
Tags: Prelims

Related Posts

Hatti community of Himachal Pradesh

Hatti community of Himachal Pradesh

April 29, 2022
De-notified, nomadic and semi-nomadic tribes

De-notified, nomadic and semi-nomadic tribes

April 6, 2022
Darlong community

Darlong community

April 6, 2022
State of World Population Report 2022

State of World Population Report 2022

March 31, 2022
World Tuberculosis (TB) Day, 2022

World Tuberculosis (TB) Day, 2022

March 25, 2022
Ol Chiki script

Ol Chiki script

March 22, 2022
World Happiness Report, 2022

World Happiness Report, 2022

March 21, 2022
Maternal mortality in India

Maternal mortality in India

March 16, 2022
International Women’s Day, 2022

International Women’s Day, 2022

March 8, 2022
Kuki tribe

Kuki tribe

March 7, 2022
Please login to join discussion

Our Offline Classroom Student

PRELIMS 2021 POLITY QUESTIONS ANALYSED

https://youtu.be/5q8hBcRGhAs

PRELIMS 2021 HISTORY QUESTIONS ANALYSED

https://youtu.be/v0SIZ7SUybg

CONGRATULATIONS TO 2020 TOPPERS !!!

Rank 25 Vaibhav Rawat 

Rank 218 Kankanala Rahul Reddy
Rank 385 Sagar A Wadi
Rank 504 Malashree MV
Rank 573 Shridevi B V
Rank 707 Mamatha G

COURSES OFFERED

PRELIMS SURESHOTS

May 2022
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
3031 
« Apr    

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tags

AIR BBC Business Standard CNN Deccan Herald DownToEarth Down to Earth DTE Economic Times ET GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express India today Indiatoday Kurukshetra LiveMint Mains News News Paper Newspaper PIB PIB & The Hindu pre Prelims PRS India RSTV Science Reporter Survey The Hindu The Hindustan Times The India Express The Indian Express The New Indian Express Times of India TOI TOPPERS UNDP website Wikipedia Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tag

AIR BBC Business Standard CNN Deccan Herald DownToEarth Down to Earth DTE Economic Times ET GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express India today Indiatoday Kurukshetra LiveMint Mains News News Paper Newspaper PIB PIB & The Hindu pre Prelims PRS India RSTV Science Reporter Survey The Hindu The Hindustan Times The India Express The Indian Express The New Indian Express Times of India TOI TOPPERS UNDP website Wikipedia Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In